AdventHealth
Quick facts
| Founded | 1973 |
|---|
Marketed products
- Postop acetaminophen IV · Pain Management
Acetaminophen reduces pain and fever by inhibiting prostaglandin synthesis in the central nervous system. - Postop hydromorphone IV · Pain Management
Hydromorphone is a mu-opioid receptor agonist that binds to opioid receptors in the central nervous system to produce analgesia and sedation. - Postop oral orphenadrine · Pain Management / Musculoskeletal
Orphenadrine is an anticholinergic agent that blocks muscarinic acetylcholine receptors to reduce muscle spasms and pain. - Postop oral oxycodone · Pain Management
Oxycodone binds to opioid receptors in the central nervous system to block pain signal transmission and provide analgesia. - Postop oral oxycodone & acetaminophen
- Postop orphenadrine IV · Pain Management / Anesthesia
Orphenadrine is an anticholinergic agent that blocks muscarinic acetylcholine receptors to reduce muscle spasms and provide analgesic effects. - Preop acetaminophen IV · Pain Management
Acetaminophen reduces pain and fever by inhibiting prostaglandin synthesis in the central nervous system. - Preop orphenadrine IV
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about AdventHealth
What are AdventHealth's marketed drugs?
Top marketed products include Postop acetaminophen IV, Postop hydromorphone IV, Postop oral orphenadrine, Postop oral oxycodone, Postop oral oxycodone & acetaminophen, Postop orphenadrine IV.
When was AdventHealth founded?
AdventHealth was founded in 1973.
Related
- Postop acetaminophen IV · Pain Management
- Postop hydromorphone IV · Pain Management
- Postop oral orphenadrine · Pain Management / Musculoskeletal
- Postop oral oxycodone · Pain Management
- Postop oral oxycodone & acetaminophen
- Sector hub: All tracked pharma companies